First-in-human study of the safety, pharmacokinetics, and

$ 24.50

4.8
(545)
In stock
Description

Pharmacokinetics, Safety, and Tolerability of NPC‐21, an Anti‐Cytome

PDF) Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8

IJMS, Free Full-Text

IJMS, Free Full-Text

Role of EGFR and FASN in breast cancer progression

The role of lipids in cancer progression and metastasis - ScienceDirect

CRO, preclinical services, PK Studies

Reviewing the role of healthy volunteer studies in drug

Biomolecules, Free Full-Text

Subcutaneous immunization with influenza and alum does not elicit

First-in-Human Study of the Safety, Pharmacokinetics, and

FASN inhibition targets multiple drivers of NASH by reducing steatosis, inflammation and fibrosis in preclinical models

Frontiers Metabolic reprogramming of clear cell renal cell carcinoma